Philip Walden Loberg Jr.

All filings by Philip Walden Loberg Jr. on record concern Valeant Pharmaceuticals International, Inc. In total, 3 filings cover trades dated from 22 December 2010 to 25 July 2011.

Every open-market trade on record is a purchase: 1 purchase worth €273k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants. So far in 2011, the count stands at 1 purchase and no sales.

The record was last updated on 27 July 2011 with a share grant in Valeant Pharmaceuticals International, Inc. The most recent open-market purchase was published on 13 June 2011, 5,613 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.